Difference between revisions of "Prostate cancer grading"

Jump to navigation Jump to search
Line 109: Line 109:
| some advocate grade 4<ref name=pmid14976541/>
| some advocate grade 4<ref name=pmid14976541/>
|-
|-
|Sarcomatoid carcinoma
| [[Sarcomatoid carcinoma of the prostate|Sarcomatoid carcinoma]]
| 5
| 5
| glands graded separately
| glands graded separately
Line 117: Line 117:
|  
|  
|-
|-
|Small cell carcinoma
|[[Small cell carcinoma of the prostate gland|Small cell carcinoma]]
| not graded (ISUP 2005 consensus<ref name=pmid16096414>{{Cite journal  | last1 = Epstein | first1 = JI. | last2 = Allsbrook | first2 = WC. | last3 = Amin | first3 = MB. | last4 = Egevad | first4 = LL. | title = The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. | journal = Am J Surg Pathol | volume = 29 | issue = 9 | pages = 1228-42 | month = Sep | year = 2005 | doi =  | PMID = 16096414 }}</ref>)
| not graded (ISUP 2005 consensus<ref name=pmid16096414>{{Cite journal  | last1 = Epstein | first1 = JI. | last2 = Allsbrook | first2 = WC. | last3 = Amin | first3 = MB. | last4 = Egevad | first4 = LL. | title = The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. | journal = Am J Surg Pathol | volume = 29 | issue = 9 | pages = 1228-42 | month = Sep | year = 2005 | doi =  | PMID = 16096414 }}</ref>)
| may be graded 5<ref name=bostwicklabs/>
| may be graded 5<ref name=bostwicklabs/>
48,460

edits

Navigation menu